Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tobacco industry weakened pesticide regulations, UCSF study shows

19.09.2005


The tobacco industry coordinated cross-industry campaigns to delay and weaken federal and international regulations on pesticide use, according to new findings by UCSF researchers.

The findings are reported in a study and commentary posted online at the pre-publication website of Environmental Health Perspectives, the journal of the National Institute of Environmental Health Sciences. The information will be published in a future issue of the journal.

Based on an analysis of internal tobacco company documents, the article outlines evidence that the tobacco industry hired ex-agency scientists to intervene in federal Environmental Protection Agency decision-making, hired a consultant to influence World Health Organization pesticide regulatory deliberations without revealing his industry ties, and staged a useless test aimed at convincing regulators that no further restrictions were needed to control an especially deadly pesticide, among other actions.



The authors point to the need for broader reform of the regulatory process to prevent abuses such as these in the future.

"This shows that the tobacco industry’s influence on our nation’s health extends far beyond policies directly concerned with smoking or cigarettes," said Ruth Malone, RN, PhD, associate professor in the UCSF School of Nursing and senior author on the study.

First author Patricia McDaniel, PhD, postdoctoral fellow at the UCSF Center for Tobacco Control Research and Education, added, "It’s one thing for the industry to participate in the public policy process by providing information or arguments, but it’s another to hire people to secretly influence the policy process and to manipulate the science guiding policymakers."

The researchers present three case studies based on examining approximately 2,000 formerly secret internal tobacco company documents as well as 3,885 EPA documents obtained under the Freedom of Information Act.

EPA standards to reduce the risks of the fumigant phosphine:

In 1998, when the EPA proposed a series of risk mitigation measures to protect workers and the community from sometimes-fatal poisoning by phosphine, tobacco interests protested that the rules would "make it virtually impossible for our industry to continue to fumigate stored tobacco."

Tobacco companies invited EPA officials to view a series of emissions tests to persuade them that a 500-foot buffer zone was not needed around fumigated warehouses. The UCSF researchers cite a Phillip Morris email to show that PM experts knew that the test methodology was flawed and the results would show no emissions problems. The PM employee wrote, "...the test plan and methods will provide, literally, no information, so it won’t hurt us to do it."

A coalition of phosphine users, including tobacco companies, hired Sciences International, a private company headed by Elizabeth Anderson, a former EPA director, to prepare a report challenging the EPA’s plan to impose stricter exposure limits for workers and the community. Anderson obtained additional funding from the coalition to publish the consultant report in Risk Analysis, a journal for which she served as editor-in-chief.

Dan Barolo, former director of EPA’s Office of Pesticide Programs, also served as a coalition consultant. In memos cited by the researchers, he emphasized the urgency of coming to agreement on the report’s contents. In one memo, he commented, "Some day they are going to figure out there is a [stricter] standard in other countries and the door will close."

Despite advice from its own toxicologists, in 1999 EPA approved the weaker regulations advocated by the tobacco and pesticide industries.

WHO safety standards for EBDC fungicides:

After the U.S. EPA determined that a breakdown product of EBDC fungicides was a probable human carcinogen in 1987, CORESTA, an international tobacco research organization, hired a consultant to provide advice on influencing international regulations on EBDC fungicide limits. Adding to WHO documentation, the authors describe how the consultant, Gaston Vettorazzi, worked with WHO officials in the capacity of an expert consultant from 1990 until 2001, influencing regulations on EBDC while concealing tobacco industry payments of as much as $100,000 a year.

Pesticide residue levels for methoprene insecticide:

In the early 1990s, Phillip Morris worked with manufacturer Zoecon in Malaysia, Italy and Germany to set pesticide residue limits that were more lax than their own data supported. Zoecon manufactures methoprene, an endocrine disruptor that prevents the larvae of cigarette beetles and tobacco moths from maturing. At Phillip Morris’ insistence, the company asked for and obtained residue limits of 15 ppm in tobacco when its own data supported a level of 10 ppm. Zoecon also collected data about international regulatory efforts on methoprene while concealing the tobacco industry’s interest in these regulations, the UCSF researchers found.

"Cynical manipulation of health protection in favor of corporate profit may not be new," said UCSF co-author Gina Solomon, MD, assistant clinical professor of medicine at UCSF and senior scientist at the Natural Resources Defense Council. "But this is the first time we’ve seen ’big tobacco’ working hand-in-glove with the big chemical companies, with the proof of the deception glaring from their own internal documents."

Janet Basu | EurekAlert!
Further information:
http://ehp.niehs.nih.gov/docs/2005/7452/abstract.html
http://www.ucsf.edu

More articles from Studies and Analyses:

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

European particle-accelerator community publishes the first industry compendium

26.04.2018 | Physics and Astronomy

Multifunctional bacterial microswimmer able to deliver cargo and destroy itself

26.04.2018 | Life Sciences

Why we need erasable MRI scans

26.04.2018 | Medical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>